Panel: Embedding Biocatalysis Upstream, When Does It Add Value & How Do You Make It Stick?

12:10 pm - Thursday 1st October 2026

  • When is the right stage to introduce biocatalysis in the development pipeline?
  • How are organizations balancing early investment with high attrition risk?
  • What has worked (and failed) when trying to shift from late-stage to early-stage adoption?
  • How do you align chemists, biologists, and process teams around a shared approach?

Speakers:

Executive Director, Process Research and Development
Eli Lilly & Co.
Senior Scientist - Process Development
Amgen Inc.
Senior Scientist
Pfizer
Senior Scientist II
Novo Nordisk